Health and Medicine

May 17, 2012

Long live the therapeutic stem cells

Enhancing stem cell survival is key to improving cell-based therapies for regenerative medicine, and a new drug could help.

By Leigh MacMillan
May 15, 2012

New clue to ADHD

A rare genetic change adds support to the idea that altered dopamine signaling is a key risk factor for ADHD.

By Bill Snyder
May 14, 2012

Intestinal artillery launches anti-bacterial attack

The epithelial cells that line the intestines have a newly discovered mechanism for protecting us against microbes: they fire anti-bacterial “bullets” into the gut.

By Leigh MacMillan
May 11, 2012

Perfect timing for sensory processing

Identification of brain regions involved in processing sights and sounds may offer insights into disorders like autism and dyslexia.

By VUMC News and Communications
eye
May 10, 2012

Vision study changes how we see the brain

Vanderbilt researchers have discovered that the pulvinar, a mysterious structure buried in the center of our brains, determines how we see the world — and whether we see at all.

By Bill Snyder
May 10, 2012

Probing epilepsy’s molecular sparks

Understanding how mutations in neuronal receptors contribute to epilepsy could lead to improved therapies.

By Leigh MacMillan
May 2, 2012

Early stomach troubles augur anxiety

Children with stomach troubles grow up to be anxious adolescents and young adults, according to a recent study.
By VUMC News and Communications
April 30, 2012

Better blood pressure-reducing drugs?

A newer version of an old class of blood pressure lowering drugs may offer advantages for obese patients with metabolic syndrome.
By Leigh MacMillan
April 27, 2012

Dengue antibodies give vaccine leads

New information may help speed development of a vaccine or treatment for dengue fever.
By VUMC News and Communications
April 26, 2012

Cost study shows timing crucial in appendectomies

Removing a child’s ruptured appendix sooner rather than later significantly lowers hospital costs and charges, according to a recently published study.
By Christina Echegaray
April 26, 2012

New drug mutes more melanomas

An experimental melanoma drug may be beneficial for patients not eligible for targeted therapies.
By VUMC News and Communications
April 20, 2012

Neuronal clues to cholesterol-defect disorder

Antioxidants may be a beneficial treatment for an inherited genetic disorder.
By Leigh MacMillan
April 19, 2012

MRSA in pregnancy may be less dangerous than previously thought

Vanderbilt pediatric infectious disease researchers studying antibiotic-resistant staph say fears that mothers carrying the germ may set their newborns up for infection are unfounded.
By VUMC News and Communications
1 … 170 171 172 173 174 … 197